Track the Integrated Biopharma INC stock price and the full insider trade history of the company, a listed equity based in United States. Shares are quoted on US US, under the supervision of SEC (Form 4). Operating in the Health Care sector, Integrated Biopharma INC has recorded 14 reports. Market capitalisation: €2.5bn. The latest transaction was filed on 22 May 2025 (Attribution). Among the most active insiders: RIVA SHEPPARD. Every trade is free.
14
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Integrated Biopharma INC Strong Buy (bullish), based on 4 analysts. Average price target: US$61.00.
30Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 5,229 of 26,213 companies
66.8
score / 100
Value
97
Quality
37
FCF yld37%
Earn yld16%
EV/EBITDA1.8x
ROE-8.4%
Gross mgn10%
Net mgn1.5%
Debt/EBITDA0.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.